GSK3B and Parkinson disease: However, Infante et al. have shown that a −413 A/T single-nucleotide polymorphism (SNP) in HO-1, together with glycogen synthase kinase-3β (GSK3β) (−157, rs6438552) TT genotype had four times higher risk of developing PD than subjects without these genotypes [89].